Goldenrod Therapeutics, 11h, Alzheimer’s Disease, ADAPT Study, PDE4 Inhibitor, Neuroinflammation, Microglia, Neurodegenerative Diseases

Houston, Texas , September 28, 2026 Goldenrod Therapeutics and investigators at the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative...